Pharma channel feed

Lil­ly en­ters ripe BTK field with quick FDA nod in man­tle cell lym­phoma

3 years ago
R&D

No­var­tis' ap­proved sick­le cell dis­ease drug fails to beat place­bo in PhI­II

3 years ago
R&D

Sen. Eliz­a­beth War­ren urges FTC to 'scru­ti­nize' two phar­ma buy­outs

3 years ago

UCB, No­vo Nordisk, Gilead rank high­est among phar­mas for HCP cus­tomer ex­pe­ri­ence — sur­vey

3 years ago
Marketing

No­vavax gets ready to take an­oth­er shot at Covid vac­cine mar­ket with next sea­son plans

3 years ago
FDA+

Post-hoc analy­sis: EMA's CHMP re­jects Ipsen's po­ten­tial drug for rare ge­net­ic dis­ease

3 years ago
FDA+

FDA ap­proves an­oth­er in­di­ca­tion for Keytru­da, this time in the ad­ju­vant NSCLC set­ting

3 years ago
R&D
FDA+

J&J, Leg­end say Carvyk­ti beat stan­dard ther­a­py in ear­li­er-line blood can­cer

3 years ago
R&D
Cell/Gene Tx

Pfiz­er lays off em­ploy­ees at Cal­i­for­nia and Con­necti­cut sites

3 years ago
People

FDA ad­vi­so­ry com­mit­tee votes unan­i­mous­ly in fa­vor of bi­va­lent Covid shots re­plac­ing pri­ma­ry se­ries

3 years ago
FDA+

FDA re­ports ini­tial 'no sig­nal' for stroke risk with Pfiz­er boost­ers, launch­es con­comi­tant flu shot study

3 years ago
FDA+

In a win for Re­gen­eron, No­var­tis' sy­ringe for AMD drug de­clared 'un­patentable'

3 years ago
Law

'Tis the sea­son: GSK ad­dress­es win­ter virus surges with celebri­ty and in­flu­encer vac­cine aware­ness cam­paigns

3 years ago
Marketing

Bris­tol My­ers claims win with CAR-T ther­a­py Breyanzi in leukemia

3 years ago
R&D

FDA cuts off use for As­traZeneca’s Covid-19 ther­a­py Evusheld

3 years ago
FDA+
Coronavirus

FDA takes next step in Tor­rent Phar­ma­ceu­ti­cal­s' trou­bled In­dia plant saga, is­sues OAI

3 years ago
FDA+
Manufacturing

FDA sends warn­ing let­ter to com­mu­ni­ty hos­pi­tal re­view board over re­search con­cerns

3 years ago
FDA+

Mer­ck halts prostate can­cer study while re­port­ing pos­i­tive read­out in bil­iary tract can­cer

3 years ago
R&D

Lon­za posts full 2022 re­sults as it looks to buy back $2B+ in shares

3 years ago
Manufacturing

No­var­tis re-en­lists spokescelebri­ty Ken Jeong for Xi­idra movie trail­er spoof cam­paign

3 years ago
Marketing

EMA changes or­phan des­ig­na­tion pol­i­cy for cer­tain eye drugs to ex­pand ac­cess

3 years ago
FDA+

Sanofi takes to Tik­Tok and In­sta­gram to tar­get mil­len­ni­als and old­er Gen Z par­ents for RSV ed­u­ca­tion

3 years ago
Marketing

J&J qui­et­ly punts a pair of ear­ly-stage bis­pecifics for sol­id tu­mors

3 years ago
R&D

Con­struc­tion on Mer­ck­'s Lon­don re­search hub set to be­gin in April 2023

3 years ago
R&D
Discovery
First page Previous page 149150151152153154155 Next page Last page
A service from the Financial Times